Transparency is so important. We want to have clinical experts and subject matter experts to be able to provide their input, but they also have to be transparent about it. We say putting their names on it does not mean that they agree with the recommendations, but we have to be transparent that they provided input into it. Otherwise, we would be hiding something, and we're not doing that; we're a transparent organization.
These are principles of good guideline development that are consistent with our best practice methods.